Oral contraceptive pill induced periodontal endocrinopathies and its management: A case report

ABSTRACT

The purpose of this article is to report a case of unusual oral contraceptive induced periodontal endocrinopathies and its treatment approach. A 32-year-old female patient, having fair oral hygiene, presented with painless, soft, diffuse gingival enlargement on severely compromised periodontium (≥ 4 mm generalized alveolar bone loss and attachment loss). The patient had on oral contraceptive over five years that was discontinued six months ago. When the lesion was not reversed following withdrawal of the pill or by repeated non-surgical measures, biopsy was performed to establish the diagnosis that revealed microscopic findings similar to that seen in gingival enlargement in pregnancy. Pocket depth, tooth mobility and gingival enlargement were reduced remarkably following periodontal surgery. After surgical intervention, close follow-up for over three years revealed no evidence of recurrence of gingival enlargement and progressive attachment loss. We conclude that periodontal surgery, patient compliance and comprehensive maintenance care are effective to return healthy periodontal status in such conditions. (Eur J Dent 2012;6:324-329)

Key words

Oral contraceptive - gingival enlargement - non-surgical measure - biopsy - attachment loss - periodontal surgery - comprehensive maintenance care

• References

• 1 Mascarenhas P, Gapski R, Al-Shammari K, Wang H-L. Influence of sex hormones on the periodontium. J Clin Periodontol 2003;30:671-681.
• 2 Mariotti A. Sex steroid hormones and cell dynamics in the periodontium. Crit Rev Oral Biol Med 1994;5:27-53.
• 3 Klokkevold PR, Mealey BL. Influence of systemic disorders and stress on the periodontium. In: Newman MG, Takei HH, Klokkevold PR, Carranza FA. Ed. Carranza’s Clinical Periodontology, 10’th Ed. St.Louis,USA:, Saunders, 284-311 2006.
• 4 Palmer R, Soory M. Modifying Factors. In: Lindhe J, Lang NP, Karring T. Ed. Clinical Periodontology and Implant Dentistry, 5’th Ed. Oxford,USA:, Blackwell Munksgaard, 307-327 2008.
• 5 Nassrawin NA, Al- Najdawi WA, Shakkoury WA. The effects of the oral contraceptive pill lo-femenal on the gingival and periodontal health. Journal of The Royal Medical Services 2010;17(Suppl 1):7-9.
• 6 Preshaw PM, Knutsen MA, Mariotti A. Experimental gingivitis in women using oral contraceptives. J Dent Res 2001;80:2011-2015.
• 7 Carranza FA, Takei HH. The periodontal flap. In: Newman MG, Takei HH, Klokkevold PR, Carranza FA. Ed. Carranza’s Clinical Periodontology, 10’th Ed. St.Louis,USA:, Saunders, 926-949 2006.
• 8 Mascarenhas P, Gapski R, Al-Shammari K, Wang H-L. Influence of sex hormones on the periodontium. J Clin Periodontol 2003;30:671–681.
• 9 Amar S, Chung KM. Influence of hormonal variation on the periodontium in women. Periodontology 2000 1994;6:79-87.
• 10 Ojanotko-Harri A. Metabolism of progesterone by healthy and inflamed human gingiva in vitro. J Steroid Biochem 1985;23:1031-1035.
• 11 Brown C, Ling F, Wan J. A new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptoms. J Reprod Med 2002;47:14-22.
• 12 Naari empowering women/Lynestrenol. URL: http://www.naari.ch/category/index/25/181/active-pharmaceuticalingredients/lynestrenol.html. Accessed June 14, 2010.
• 13 Otomo-Corgel J. Periodontal therapy in the female patient. In: Newman MG, Takei HH, Klokkevold PR, Carranza FA. Ed. Carranza’s Clinical Periodontology, 10’th Ed. St.Louis,USA:, Saunders, 636-649 2006.
• 14 Raber-Durlacher JE, Van Steenbergen TJM, Van der Velden U, De Graaff J, Abraham-Inpijn L. Experimental gingivitis during pregnancy and post-partum: clinical, endocrinological and microbiological aspects. J Clin Periodontol 1994;21:549-558.
• 15 Tilakaratne A, Soory M, Ranasinghe AW, Corea SMX, Ekanayake SL, De Silva M. Effects of hormonal contraceptives on the periodontium in a population of rural Sri-Lankan women. J Clin Periodontol 2000;27:753-757.